The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study
Clinical trial NCT04909866 · UNKNOWN
Trial details
- NCT number
- NCT04909866
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.